Anal Fistula Surgical Treatment Market size is predicted to expand at a substantial rate between 2023 and 2032 due to rising cases of Crohn's disease, tuberculosis, and STDs.
High prevalence of chronic diarrhea in emerging economies has driven the demand for fistula repair procedures. Anal fistula is a common benign disease that results in an infection that causes pus, swelling, and agony. It mostly occurs due to the development of an abscess in an anal gland. Surgical procedures like seton methods, fistulotomy, bioprosthetic plugs, and advancement flap procedures are used to treat this condition. An increase in the number of patients with inflammatory bowel disease and rising healthcare spending will support the adoption of advanced surgical fistula treatment options.
Based on treatment, the fistulotomy segment is expected to account for a major share of the anal fistula surgical treatment market by 2032. Fistulotomy procedure is used to remove fluid and pus from fistulated tissues so that they can heal. Medical practitioners and surgeons are preferring this treatment option as it lessen damage to the anal sphincter. Benefits like faster healing and the ability to close abnormal gaps should boost the adoption of these procedures in the coming years.
Considering anal fistula type, the transphincteric fistulas segment is expected to hold a notable share of the market. Transphincteric fistulas are one of the most common types of anal fistula. It requires fistula surgical therapy due to the high risk of recurrences. The development of new surgical therapy options and robust expansion in the medical tourism sector across the United States and Europe should facilitate segment growth over the forecast period.
From the regional viewpoint, the North America anal fistula surgical treatment market is expected to grow at a decent rate due to a noticeable increase in the number of people with inflammatory bowel disease (IBD). According to a CDC report, around 3.1 million adults (1.3%) in the US have been diagnosed with IBD, which include ulcerative colitis and Crohn’s disease. The disease constitutes to chronic inflammation of the gastrointestinal tract and has prompted the need for better treatment options. Additionally, high prevalence of AIDS in the region has increased the uptake of sophisticated flap surgeries and seton techniques.
According to the competitive landscape, the worldwide anal fistula surgical treatment market comprises of key companies like St. Mark's Hospital, Renacres Hospital, Bumrungrad International Hospital, Royal Prince Alfred Hospital, Apollo Hospitals Enterprise Ltd., Stanford Health Care, Alberta Health Services, Fortis Healthcare, and Sikarin Hospital. Companies are making new investments, product launches, R&D, and innovations to extent their business footprint.
The Russia-Ukraine war is expected to have a negative impact on the anal fistula surgical treatment industry to some extent. The conflict led to disruption in the supply chain and a surge in the demand for medical supplies like antibiotics, needles, and wound dressings for treating war-related injuries. Suspension of non-essential surgeries and hospitalizations due to power blackouts led to a decline in the demand for anal fistula surgical treatments across these nations.